Charming Medical Limited
MCTA
$29.36
$1.866.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 365.10K | 365.10K | 234.40K | 234.40K | 201.70K |
| Total Depreciation and Amortization | 53.80K | 53.80K | 78.00K | 78.00K | 100.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.50K | 39.50K | 22.50K | 22.50K | 19.50K |
| Change in Net Operating Assets | -411.70K | -411.70K | -168.60K | -168.60K | -395.80K |
| Cash from Operations | 46.70K | 46.70K | 166.20K | 166.20K | -73.70K |
| Capital Expenditure | -58.60K | -58.60K | -85.10K | -85.10K | -2.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -971.00K | -971.00K | -- | -- | -- |
| Cash from Investing | -1.03M | -1.03M | -85.10K | -85.10K | -2.30K |
| Total Debt Issued | 59.70K | 59.70K | 43.20K | 43.20K | -17.10K |
| Total Debt Repaid | -47.30K | -47.30K | -31.20K | -31.20K | -36.70K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 30.10K | 30.10K | 206.10K | 206.10K | 605.50K |
| Cash from Financing | 42.50K | 42.50K | 218.10K | 218.10K | 551.60K |
| Foreign Exchange rate Adjustments | 2.70K | 2.70K | -5.00K | -5.00K | -12.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -937.60K | -937.60K | 294.20K | 294.20K | 463.00K |